Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06880640 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Affect-based Impulsivity in Borderline Personality Disorder

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial completed Final enrollment: 76 participants (planned 106) · Primary and study completion dates changed from estimate of Aug 2026 to Aug 13, 2026 · Eligibility criteria expanded, about 18 words · 3 more Show 6 more changesShow less
    • Final enrollment: 76 participants (planned 106)
    • Primary and study completion dates changed from estimate of Aug 2026 to Aug 13, 2026
    • Eligibility criteria expanded, about 18 words
    • Secondary endpoints: details revised at 1 of 1 entry
    • Site details revised
    • Publications: details revised at 1 of 1 entry
  2. Site contact updatedv7
  3. Start date changed from estimate of Sep 2025 to Sep 21, 2025v6
  4. Primary and study completion dates: Mar 31, 2026 to Aug 2026v5
  5. Primary and study completion dates: Sep 1, 2026 to Mar 31, 2026 Start date: Sep 2, 2025 to Sep 2025v4 Show 1 more changeShow less
    • Start date: Sep 2, 2025 to Sep 2025
Show 2 earlier versionsHide 2 earlier versions
  1. Start date: May 10, 2025 to Sep 2, 2025 Primary and study completion dates: Apr 1, 2026 to Sep 1, 2026v3 Show 1 more changeShow less
    • Primary and study completion dates: Apr 1, 2026 to Sep 1, 2026
  2. Trial status: Not Yet Recruiting to Recruiting Start date: Apr 1, 2025 to May 10, 2025 · Eligibility criteria expanded, about 6 words · Site details revisedv2 Show 3 more changesShow less
    • Start date: Apr 1, 2025 to May 10, 2025
    • Eligibility criteria expanded, about 6 words
    • Site details revised

    See this version in full on ClinicalTrials.gov ↗

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this research study is to investigate how personality traits and neuroendocrine systems relate to decision-making patterns in individuals 18-45 years old. The main question it aims to answer is how neuroendocrine activity impacts decision-making. Participants will complete online behavioral tasks, a stress induction procedure, self-report surveys, and a cognitive assessment. During the session, psychophysiological measures will be collected, including electrocardiogram (ECG) and cardiac impedance (ICG) to monitor heart rate and blood flow, as well as electrodermal activity (EDA), blood drop samples, and saliva collection to assess nervous system activity.
Trial Details
NCT Number NCT06880640
Lead Sponsor University of North Carolina, Chapel Hill
Collaborators: North Carolina Translational and Clinical Sciences Institute
Conditions Borderline Personality Disorder (BPD), Healthy Controls Group - Age and Sex-matched
Enrollment 76 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov